FDA Investigator: Kara D. Dobbin
- Kara D. Dobbin first started conducting FDA inspections in 2015, with the last inspection in 2020. Over that time, Kara D. Dobbin has conducted 46 inspections at 46 companies across 45 sites.
Get Kara Dobbin's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Lifequest Creations, Marietta | March 2020
Available Now - $199
Kara D. Dobbin
Human Drug Form 483
FDA EIR Beiersdorf Manufacturing, Cleveland | November 2019
Available Now - $995
Kara D. Dobbin
Human Drug Form 483
FDA 483 Asanuma - Sagamihara Factory, Sagamihara | Feb 2017
Available Now - $199
Kara D. Dobbin
Human Drug Form 483
FDA 483 Scapa Tapes North America LLC, Knoxville | 2020
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Wuhan Humanwell Likang Pharmaceutical Co., Ltd., Wuhan | 2019
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Pharmadax (Foshan) Co., Ltd., Foshan | 2019
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Sunshine Lake Pharma Co., Ltd, Dongguan | 2019
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Kremoint Pharma Private Limited, Mumbai | 2019
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Zhejiang Dingtai Pharmaceutical Co., Ltd, Tongxiang | 2019
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Symrise, S. de R.L de C.V., San Nicolas De Los Garza | 2018
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Vetoquinol N.-A., Princeville | 2018
Out-of-stock
Kara D. Dobbin
Animal Drugs & Feed Form 483
FDA 483 Choksi Laboratories Limited, Indore | 2018
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Seema International, New Delhi | 2018
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 JIANGXI TIANXIN PHARMACEUTICAL CO.,LTD., Jingdezhen | 2018
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Estee Lauder Cosmetics Ltd., Scarborough | 2017
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Laboratoires Dermo-Cosmetik Inc., Saint-Laurent | 2017
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Quality Chemical Laboratories, LLC, Wilmington | 2017
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Xellia Pharmaceuticals USA LLC, Raleigh | 2017
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Procter & Gamble Manufacturing Co, Browns Summit | 2017
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Katayama Seiyakusyo Co., Ltd., Hirakata | 2017
Out-of-stock
Kara D. Dobbin
Animal Drugs & Feed Form 483
FDA 483 Daiichi Fine Chemical Co Ltd, Takaoka | 2017
Out-of-stock
Kara D. Dobbin
Animal Drugs & Feed Form 483
FDA 483 Clean Advantage, Inc., Taylors | 2016
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 PDQ Manufacturing Inc, Ellijay | 2016
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Fresenius Kabi USA, LLC, Wilson | 2016
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
FDA 483 Waveform Inc, Marietta | 2016
Out-of-stock
Kara D. Dobbin
Human Drug Form 483
Co-Investigators (18)
- Steven J. Rush, FDA Investigator
- Dmitry Gazarian, FDA Investigator
- Ruo H. Xu, FDA Investigator
- Reba A. Gates, FDA Investigator
- Tajah L. Blackburn, FDA Investigator
- Daveta L. Bailey, FDA Investigator
- Christopher S. Keating, FDA Investigator
- Jawaid Hamid, FDA Investigator
- Lillie D. Witcher, FDA Investigator
- Seneca D. Toms, FDA Investigator
- Sandra I. Gaul, FDA Investigator
- Bonita S. Chester, FDA Investigator
- Sharna D. Pratt, FDA Investigator
- Metitia M. Gramby, FDA Investigator
- Metitia G. Sanders, FDA Investigator
- Robin N. Goins, FDA Investigator
- Douglas L. Page, FDA Investigator
- Vincent M. Williams, FDA Investigator